Complications of Ethanol-amine Oleate Intralesional Sclerotherapy

Suez Canal University15 enrolled

Overview

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients

Maxillofacial Venous malformations cause many functional and esthetic complications in children, intralesional sclerotherapy is the best choice of treatment; and Ethanol-amine Oleate has been the most commonly used sclerosing agent. The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations

Study Type

OBSERVATIONAL

Enrollment

Conditions

Venous Malformation

Interventions

Ethanol-amine Oleate Sclerotherapy InjectionDRUG

Intralesional Sclerotherapy Injection

Eligibility

Sex: ALLMax age: 12 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: maxillofacial venous malformation \- Exclusion Criteria: 1. Patients with lung, liver, or kidney diseases 2. Patients with Klippel-Trenaunay syndrome 3. Patients mental or physical disabilities

Locations (1)

Suez Canal University

Ismailia, Egypt

Outcomes

Primary Outcomes

Clinical Response

Complete Response - Marked Improvement - Moderate Improvement - No Response

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.